Evidence map›Paper›PMID 27338702›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Hypophosphatemia promotes lower rates of muscle ATP synthesis.

Dominik H Pesta, Dimitrios N Tsirigotis, Douglas E Befroy, Daniel Caballero, Michael J Jurczak, Yasmeen Rahimi, Gary W Cline, Sylvie Dufour, Andreas L Birkenfeld, Douglas L Rothman and 5 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04146935 (Examining the Effect of Burosumab on Muscle Function Using MR Spectroscopy), which is not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04146935 phase4completednot on this mapstarted 2019, after this paper: background citation

Examining the Effect of Burosumab on Muscle Function Using MR Spectroscopy

TypeinterventionalSponsorYale UniversityRan2019 to 2022Enrolled10ConditionsX-linked HypophosphatemiaArmsBurosumab Injection [Crysvita]
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Phosphorus Metabolism and Function in Ruminants: Current Knowledge.Animals : an open access journal from MDPI · 2026
    Review
  9. Supplements for bone health.Archives of endocrinology and metabolism · 2025
    Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Dominik H PestaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Dimitrios N TsirigotisDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Douglas E BefroyDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, Connecticut, USA.
Daniel CaballeroDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Michael J JurczakDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Yasmeen RahimiDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Gary W ClineDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Sylvie DufourHoward Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Andreas L BirkenfeldDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Douglas L RothmanDepartment of Radiology and Biomedical Engineering, Yale University School of Medicine, New Haven, Connecticut, USA.
Thomas O CarpenterDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA; and.
Karl InsognaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Kitt Falk PetersenDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Clemens BergwitzDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Gerald I ShulmanDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark gerald.shulman@yale.edu.
Yale University · USHoward Hughes Medical Institute · USNovo Nordisk Foundation · DK

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
Mechanism of Insulin Resistance in the Aged.R01AG023686 · NIA · YALE UNIVERSITY · PI PETERSEN, KITT F · 2003 to 2014
$3.4M
Mechanism of Insulin Resistance in the Aged.R56AG023686 · NIA · YALE UNIVERSITY · PI PETERSEN, KITT F · 2009 to 2009
$414k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NIA NIH HHS R01 AG023686NIA NIH HHS R56 AG023686NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK040936NIDDK NIH HHS U24 DK059635
6 · The paper itself

Abstract

Hypophosphatemia can lead to muscle weakness and respiratory and heart failure, but the mechanism is unknown. To address this question, we noninvasively assessed rates of muscle ATP synthesis in hypophosphatemic mice by using in vivo saturation transfer [

Indexed as

Adenosine TriphosphateAnimalsHumansHypophosphatemiaInsulinMagnetic Resonance SpectroscopyMaleMice, Inbred C57BLMice, KnockoutMitochondria, MuscleMuscle, SkeletalMuscle WeaknessPhosphatesAdenosine TriphosphateInsulinPhosphates[31P]MRSinorganic phosphatesaturation transfer

Identifiers

PMID27338702
PMCPMC5024687
OpenAlexW2469427057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.